Rzany, B.
67  results:
Search for persons X
?
1

Too many instruments for measuring Quality of Life in Atopi..:

Rzany, B.
Journal of the European Academy of Dermatology and Venereology.  31 (2017)  4 - p. 574-574 , 2017
 
?
2

An open, multicentre, randomized clinical study in patients..:

Sticherling, M. ; Franke, A. ; Aberer, E....
British Journal of Dermatology.  177 (2017)  5 - p. 1299-1305 , 2017
 
?
3

Adverse reactions to fillers should be published – on the c..:

Rzany, B.
Journal of the European Academy of Dermatology and Venereology.  31 (2017)  7 - p. 1087-1087 , 2017
 
?
4

The impact of adverse reactions to injectable filler substa..:

Düker, D. ; Erdmann, R. ; Hartmann, V....
Journal of the European Academy of Dermatology and Venereology.  30 (2016)  6 - p. 1013-1020 , 2016
 
?
5

Fehlbehandlung mit injizierbaren Fillern:

Rzany, B.
Journal für Ästhetische Chirurgie.  9 (2016)  4 - p. 173-177 , 2016
 
?
7

Reduction of unwanted submental fat withATX‐101 (deoxycholi..:

Rzany, B. ; Griffiths, T. ; Walker, P....
British Journal of Dermatology.  170 (2014)  2 - p. 445-453 , 2014
 
?
11

German S3-guidelines on the treatment of psoriasis vulgaris..:

Nast, A. ; Boehncke, W. H. ; Mrowietz, U....
Archives of Dermatological Research.  304 (2012)  2 - p. 87-113 , 2012
 
?
13

European Evidence-based (S3) Guidelines for the Treatment o..:

Nast, A. ; Dréno, B. ; Bettoli, V....
Journal of the European Academy of Dermatology and Venereology.  26 (2012)  - p. 1-29 , 2012
 
?
14

Methods report on the development of the European S3 guidel..:

Nast, A. ; Rosumeck, S. ; Sammain, A...
Journal of the European Academy of Dermatology and Venereology.  26 (2012)  - p. e1-e39 , 2012
 
?
15

Efficacy and safety of methantheline bromide (Vagantin®) in..:

Müller, C. ; Berensmeier, A. ; Hamm, H....
Journal of the European Academy of Dermatology and Venereology.  27 (2012)  10 - p. 1278-1284 , 2012
 
1-15